Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Cardiac Marker Market Growth 2022-2028

  • LP 4742053
  • 103 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Cardiac Marker will have significant change from previous year. According to our (LP Information) latest study, the global Cardiac Marker market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cardiac Marker market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Cardiac Marker market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cardiac Marker market, reaching US$ million by the year 2028. As for the Europe Cardiac Marker landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Cardiac Marker players cover HyTest, Abbott, Roche Diagnostics, and BG Medicine, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiac Marker market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Creatine kinase (CK) MB

Troponin (cTnI and cTnT)

BNP & NT-proBNP

Myogloblin

Others (hs-CRP, D-Dimer, etc.)

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Myocardial Infarction

Congestive Heart Failure

Acute Coronary Syndrome

Atherosclerosis

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

HyTest

Abbott

Roche Diagnostics

BG Medicine

Biomerieux

Critical Diagnostics

DiaDexus

Response Biomedical

Siemens Healthcare

Singulex

Thermo Scientific

Trinity Biotech

Sunfory

Lee BioSolutions

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cardiac Marker Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Cardiac Marker by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Cardiac Marker by Country/Region, 2017, 2022 & 2028

2.2 Cardiac Marker Segment by Type

2.2.1 Creatine kinase (CK) MB

2.2.2 Troponin (cTnI and cTnT)

2.2.3 BNP & NT-proBNP

2.2.4 Myogloblin

2.2.5 Others (hs-CRP, D-Dimer, etc.)

2.3 Cardiac Marker Sales by Type

2.3.1 Global Cardiac Marker Sales Market Share by Type (2017-2022)

2.3.2 Global Cardiac Marker Revenue and Market Share by Type (2017-2022)

2.3.3 Global Cardiac Marker Sale Price by Type (2017-2022)

2.4 Cardiac Marker Segment by Application

2.4.1 Myocardial Infarction

2.4.2 Congestive Heart Failure

2.4.3 Acute Coronary Syndrome

2.4.4 Atherosclerosis

2.4.5 Others

2.5 Cardiac Marker Sales by Application

2.5.1 Global Cardiac Marker Sale Market Share by Application (2017-2022)

2.5.2 Global Cardiac Marker Revenue and Market Share by Application (2017-2022)

2.5.3 Global Cardiac Marker Sale Price by Application (2017-2022)

3 Global Cardiac Marker by Company

3.1 Global Cardiac Marker Breakdown Data by Company

3.1.1 Global Cardiac Marker Annual Sales by Company (2020-2022)

3.1.2 Global Cardiac Marker Sales Market Share by Company (2020-2022)

3.2 Global Cardiac Marker Annual Revenue by Company (2020-2022)

3.2.1 Global Cardiac Marker Revenue by Company (2020-2022)

3.2.2 Global Cardiac Marker Revenue Market Share by Company (2020-2022)

3.3 Global Cardiac Marker Sale Price by Company

3.4 Key Manufacturers Cardiac Marker Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Cardiac Marker Product Location Distribution

3.4.2 Players Cardiac Marker Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Cardiac Marker by Geographic Region

4.1 World Historic Cardiac Marker Market Size by Geographic Region (2017-2022)

4.1.1 Global Cardiac Marker Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Cardiac Marker Annual Revenue by Geographic Region

4.2 World Historic Cardiac Marker Market Size by Country/Region (2017-2022)

4.2.1 Global Cardiac Marker Annual Sales by Country/Region (2017-2022)

4.2.2 Global Cardiac Marker Annual Revenue by Country/Region

4.3 Americas Cardiac Marker Sales Growth

4.4 APAC Cardiac Marker Sales Growth

4.5 Europe Cardiac Marker Sales Growth

4.6 Middle East & Africa Cardiac Marker Sales Growth

5 Americas

5.1 Americas Cardiac Marker Sales by Country

5.1.1 Americas Cardiac Marker Sales by Country (2017-2022)

5.1.2 Americas Cardiac Marker Revenue by Country (2017-2022)

5.2 Americas Cardiac Marker Sales by Type

5.3 Americas Cardiac Marker Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cardiac Marker Sales by Region

6.1.1 APAC Cardiac Marker Sales by Region (2017-2022)

6.1.2 APAC Cardiac Marker Revenue by Region (2017-2022)

6.2 APAC Cardiac Marker Sales by Type

6.3 APAC Cardiac Marker Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Cardiac Marker by Country

7.1.1 Europe Cardiac Marker Sales by Country (2017-2022)

7.1.2 Europe Cardiac Marker Revenue by Country (2017-2022)

7.2 Europe Cardiac Marker Sales by Type

7.3 Europe Cardiac Marker Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cardiac Marker by Country

8.1.1 Middle East & Africa Cardiac Marker Sales by Country (2017-2022)

8.1.2 Middle East & Africa Cardiac Marker Revenue by Country (2017-2022)

8.2 Middle East & Africa Cardiac Marker Sales by Type

8.3 Middle East & Africa Cardiac Marker Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Cardiac Marker

10.3 Manufacturing Process Analysis of Cardiac Marker

10.4 Industry Chain Structure of Cardiac Marker

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Cardiac Marker Distributors

11.3 Cardiac Marker Customer

12 World Forecast Review for Cardiac Marker by Geographic Region

12.1 Global Cardiac Marker Market Size Forecast by Region

12.1.1 Global Cardiac Marker Forecast by Region (2023-2028)

12.1.2 Global Cardiac Marker Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Cardiac Marker Forecast by Type

12.7 Global Cardiac Marker Forecast by Application

13 Key Players Analysis

13.1 HyTest

13.1.1 HyTest Company Information

13.1.2 HyTest Cardiac Marker Product Offered

13.1.3 HyTest Cardiac Marker Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 HyTest Main Business Overview

13.1.5 HyTest Latest Developments

13.2 Abbott

13.2.1 Abbott Company Information

13.2.2 Abbott Cardiac Marker Product Offered

13.2.3 Abbott Cardiac Marker Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Abbott Main Business Overview

13.2.5 Abbott Latest Developments

13.3 Roche Diagnostics

13.3.1 Roche Diagnostics Company Information

13.3.2 Roche Diagnostics Cardiac Marker Product Offered

13.3.3 Roche Diagnostics Cardiac Marker Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Roche Diagnostics Main Business Overview

13.3.5 Roche Diagnostics Latest Developments

13.4 BG Medicine

13.4.1 BG Medicine Company Information

13.4.2 BG Medicine Cardiac Marker Product Offered

13.4.3 BG Medicine Cardiac Marker Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 BG Medicine Main Business Overview

13.4.5 BG Medicine Latest Developments

13.5 Biomerieux

13.5.1 Biomerieux Company Information

13.5.2 Biomerieux Cardiac Marker Product Offered

13.5.3 Biomerieux Cardiac Marker Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Biomerieux Main Business Overview

13.5.5 Biomerieux Latest Developments

13.6 Critical Diagnostics

13.6.1 Critical Diagnostics Company Information

13.6.2 Critical Diagnostics Cardiac Marker Product Offered

13.6.3 Critical Diagnostics Cardiac Marker Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Critical Diagnostics Main Business Overview

13.6.5 Critical Diagnostics Latest Developments

13.7 DiaDexus

13.7.1 DiaDexus Company Information

13.7.2 DiaDexus Cardiac Marker Product Offered

13.7.3 DiaDexus Cardiac Marker Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 DiaDexus Main Business Overview

13.7.5 DiaDexus Latest Developments

13.8 Response Biomedical

13.8.1 Response Biomedical Company Information

13.8.2 Response Biomedical Cardiac Marker Product Offered

13.8.3 Response Biomedical Cardiac Marker Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Response Biomedical Main Business Overview

13.8.5 Response Biomedical Latest Developments

13.9 Siemens Healthcare

13.9.1 Siemens Healthcare Company Information

13.9.2 Siemens Healthcare Cardiac Marker Product Offered

13.9.3 Siemens Healthcare Cardiac Marker Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Siemens Healthcare Main Business Overview

13.9.5 Siemens Healthcare Latest Developments

13.10 Singulex

13.10.1 Singulex Company Information

13.10.2 Singulex Cardiac Marker Product Offered

13.10.3 Singulex Cardiac Marker Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Singulex Main Business Overview

13.10.5 Singulex Latest Developments

13.11 Thermo Scientific

13.11.1 Thermo Scientific Company Information

13.11.2 Thermo Scientific Cardiac Marker Product Offered

13.11.3 Thermo Scientific Cardiac Marker Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Thermo Scientific Main Business Overview

13.11.5 Thermo Scientific Latest Developments

13.12 Trinity Biotech

13.12.1 Trinity Biotech Company Information

13.12.2 Trinity Biotech Cardiac Marker Product Offered

13.12.3 Trinity Biotech Cardiac Marker Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Trinity Biotech Main Business Overview

13.12.5 Trinity Biotech Latest Developments

13.13 Sunfory

13.13.1 Sunfory Company Information

13.13.2 Sunfory Cardiac Marker Product Offered

13.13.3 Sunfory Cardiac Marker Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Sunfory Main Business Overview

13.13.5 Sunfory Latest Developments

13.14 Lee BioSolutions

13.14.1 Lee BioSolutions Company Information

13.14.2 Lee BioSolutions Cardiac Marker Product Offered

13.14.3 Lee BioSolutions Cardiac Marker Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Lee BioSolutions Main Business Overview

13.14.5 Lee BioSolutions Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Cardiac Marker Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Cardiac Marker Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Creatine kinase (CK) MB

Table 4. Major Players of Troponin (cTnI and cTnT)

Table 5. Major Players of BNP & NT-proBNP

Table 6. Major Players of Myogloblin

Table 7. Major Players of Others (hs-CRP, D-Dimer, etc.)

Table 8. Global Cardiac Marker Sales by Type (2017-2022) & (K Doses)

Table 9. Global Cardiac Marker Sales Market Share by Type (2017-2022)

Table 10. Global Cardiac Marker Revenue by Type (2017-2022) & ($ million)

Table 11. Global Cardiac Marker Revenue Market Share by Type (2017-2022)

Table 12. Global Cardiac Marker Sale Price by Type (2017-2022) & (USD/Dose)

Table 13. Global Cardiac Marker Sales by Application (2017-2022) & (K Doses)

Table 14. Global Cardiac Marker Sales Market Share by Application (2017-2022)

Table 15. Global Cardiac Marker Revenue by Application (2017-2022)

Table 16. Global Cardiac Marker Revenue Market Share by Application (2017-2022)

Table 17. Global Cardiac Marker Sale Price by Application (2017-2022) & (USD/Dose)

Table 18. Global Cardiac Marker Sales by Company (2020-2022) & (K Doses)

Table 19. Global Cardiac Marker Sales Market Share by Company (2020-2022)

Table 20. Global Cardiac Marker Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Cardiac Marker Revenue Market Share by Company (2020-2022)

Table 22. Global Cardiac Marker Sale Price by Company (2020-2022) & (USD/Dose)

Table 23. Key Manufacturers Cardiac Marker Producing Area Distribution and Sales Area

Table 24. Players Cardiac Marker Products Offered

Table 25. Cardiac Marker Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Cardiac Marker Sales by Geographic Region (2017-2022) & (K Doses)

Table 29. Global Cardiac Marker Sales Market Share Geographic Region (2017-2022)

Table 30. Global Cardiac Marker Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Cardiac Marker Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Cardiac Marker Sales by Country/Region (2017-2022) & (K Doses)

Table 33. Global Cardiac Marker Sales Market Share by Country/Region (2017-2022)

Table 34. Global Cardiac Marker Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Cardiac Marker Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Cardiac Marker Sales by Country (2017-2022) & (K Doses)

Table 37. Americas Cardiac Marker Sales Market Share by Country (2017-2022)

Table 38. Americas Cardiac Marker Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Cardiac Marker Revenue Market Share by Country (2017-2022)

Table 40. Americas Cardiac Marker Sales by Type (2017-2022) & (K Doses)

Table 41. Americas Cardiac Marker Sales Market Share by Type (2017-2022)

Table 42. Americas Cardiac Marker Sales by Application (2017-2022) & (K Doses)

Table 43. Americas Cardiac Marker Sales Market Share by Application (2017-2022)

Table 44. APAC Cardiac Marker Sales by Region (2017-2022) & (K Doses)

Table 45. APAC Cardiac Marker Sales Market Share by Region (2017-2022)

Table 46. APAC Cardiac Marker Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Cardiac Marker Revenue Market Share by Region (2017-2022)

Table 48. APAC Cardiac Marker Sales by Type (2017-2022) & (K Doses)

Table 49. APAC Cardiac Marker Sales Market Share by Type (2017-2022)

Table 50. APAC Cardiac Marker Sales by Application (2017-2022) & (K Doses)

Table 51. APAC Cardiac Marker Sales Market Share by Application (2017-2022)

Table 52. Europe Cardiac Marker Sales by Country (2017-2022) & (K Doses)

Table 53. Europe Cardiac Marker Sales Market Share by Country (2017-2022)

Table 54. Europe Cardiac Marker Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Cardiac Marker Revenue Market Share by Country (2017-2022)

Table 56. Europe Cardiac Marker Sales by Type (2017-2022) & (K Doses)

Table 57. Europe Cardiac Marker Sales Market Share by Type (2017-2022)

Table 58. Europe Cardiac Marker Sales by Application (2017-2022) & (K Doses)

Table 59. Europe Cardiac Marker Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Cardiac Marker Sales by Country (2017-2022) & (K Doses)

Table 61. Middle East & Africa Cardiac Marker Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Cardiac Marker Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Cardiac Marker Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Cardiac Marker Sales by Type (2017-2022) & (K Doses)

Table 65. Middle East & Africa Cardiac Marker Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Cardiac Marker Sales by Application (2017-2022) & (K Doses)

Table 67. Middle East & Africa Cardiac Marker Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Cardiac Marker

Table 69. Key Market Challenges & Risks of Cardiac Marker

Table 70. Key Industry Trends of Cardiac Marker

Table 71. Cardiac Marker Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Cardiac Marker Distributors List

Table 74. Cardiac Marker Customer List

Table 75. Global Cardiac Marker Sales Forecast by Region (2023-2028) & (K Doses)

Table 76. Global Cardiac Marker Sales Market Forecast by Region

Table 77. Global Cardiac Marker Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Cardiac Marker Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Cardiac Marker Sales Forecast by Country (2023-2028) & (K Doses)

Table 80. Americas Cardiac Marker Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Cardiac Marker Sales Forecast by Region (2023-2028) & (K Doses)

Table 82. APAC Cardiac Marker Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Cardiac Marker Sales Forecast by Country (2023-2028) & (K Doses)

Table 84. Europe Cardiac Marker Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Cardiac Marker Sales Forecast by Country (2023-2028) & (K Doses)

Table 86. Middle East & Africa Cardiac Marker Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Cardiac Marker Sales Forecast by Type (2023-2028) & (K Doses)

Table 88. Global Cardiac Marker Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Cardiac Marker Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Cardiac Marker Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Cardiac Marker Sales Forecast by Application (2023-2028) & (K Doses)

Table 92. Global Cardiac Marker Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Cardiac Marker Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Cardiac Marker Revenue Market Share Forecast by Application (2023-2028)

Table 95. HyTest Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors

Table 96. HyTest Cardiac Marker Product Offered

Table 97. HyTest Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 98. HyTest Main Business

Table 99. HyTest Latest Developments

Table 100. Abbott Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors

Table 101. Abbott Cardiac Marker Product Offered

Table 102. Abbott Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 103. Abbott Main Business

Table 104. Abbott Latest Developments

Table 105. Roche Diagnostics Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors

Table 106. Roche Diagnostics Cardiac Marker Product Offered

Table 107. Roche Diagnostics Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 108. Roche Diagnostics Main Business

Table 109. Roche Diagnostics Latest Developments

Table 110. BG Medicine Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors

Table 111. BG Medicine Cardiac Marker Product Offered

Table 112. BG Medicine Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 113. BG Medicine Main Business

Table 114. BG Medicine Latest Developments

Table 115. Biomerieux Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors

Table 116. Biomerieux Cardiac Marker Product Offered

Table 117. Biomerieux Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 118. Biomerieux Main Business

Table 119. Biomerieux Latest Developments

Table 120. Critical Diagnostics Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors

Table 121. Critical Diagnostics Cardiac Marker Product Offered

Table 122. Critical Diagnostics Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 123. Critical Diagnostics Main Business

Table 124. Critical Diagnostics Latest Developments

Table 125. DiaDexus Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors

Table 126. DiaDexus Cardiac Marker Product Offered

Table 127. DiaDexus Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 128. DiaDexus Main Business

Table 129. DiaDexus Latest Developments

Table 130. Response Biomedical Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors

Table 131. Response Biomedical Cardiac Marker Product Offered

Table 132. Response Biomedical Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 133. Response Biomedical Main Business

Table 134. Response Biomedical Latest Developments

Table 135. Siemens Healthcare Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors

Table 136. Siemens Healthcare Cardiac Marker Product Offered

Table 137. Siemens Healthcare Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 138. Siemens Healthcare Main Business

Table 139. Siemens Healthcare Latest Developments

Table 140. Singulex Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors

Table 141. Singulex Cardiac Marker Product Offered

Table 142. Singulex Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 143. Singulex Main Business

Table 144. Singulex Latest Developments

Table 145. Thermo Scientific Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors

Table 146. Thermo Scientific Cardiac Marker Product Offered

Table 147. Thermo Scientific Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 148. Thermo Scientific Main Business

Table 149. Thermo Scientific Latest Developments

Table 150. Trinity Biotech Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors

Table 151. Trinity Biotech Cardiac Marker Product Offered

Table 152. Trinity Biotech Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 153. Trinity Biotech Main Business

Table 154. Trinity Biotech Latest Developments

Table 155. Sunfory Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors

Table 156. Sunfory Cardiac Marker Product Offered

Table 157. Sunfory Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 158. Sunfory Main Business

Table 159. Sunfory Latest Developments

Table 160. Lee BioSolutions Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors

Table 161. Lee BioSolutions Cardiac Marker Product Offered

Table 162. Lee BioSolutions Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 163. Lee BioSolutions Main Business

Table 164. Lee BioSolutions Latest Developments

List of Figures

Figure 1. Picture of Cardiac Marker

Figure 2. Cardiac Marker Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Cardiac Marker Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Cardiac Marker Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Cardiac Marker Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Creatine kinase (CK) MB

Figure 10. Product Picture of Troponin (cTnI and cTnT)

Figure 11. Product Picture of BNP & NT-proBNP

Figure 12. Product Picture of Myogloblin

Figure 13. Product Picture of Others (hs-CRP, D-Dimer, etc.)

Figure 14. Global Cardiac Marker Sales Market Share by Type in 2021

Figure 15. Global Cardiac Marker Revenue Market Share by Type (2017-2022)

Figure 16. Cardiac Marker Consumed in Myocardial Infarction

Figure 17. Global Cardiac Marker Market: Myocardial Infarction (2017-2022) & (K Doses)

Figure 18. Cardiac Marker Consumed in Congestive Heart Failure

Figure 19. Global Cardiac Marker Market: Congestive Heart Failure (2017-2022) & (K Doses)

Figure 20. Cardiac Marker Consumed in Acute Coronary Syndrome

Figure 21. Global Cardiac Marker Market: Acute Coronary Syndrome (2017-2022) & (K Doses)

Figure 22. Cardiac Marker Consumed in Atherosclerosis

Figure 23. Global Cardiac Marker Market: Atherosclerosis (2017-2022) & (K Doses)

Figure 24. Cardiac Marker Consumed in Others

Figure 25. Global Cardiac Marker Market: Others (2017-2022) & (K Doses)

Figure 26. Global Cardiac Marker Sales Market Share by Application (2017-2022)

Figure 27. Global Cardiac Marker Revenue Market Share by Application in 2021

Figure 28. Cardiac Marker Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Cardiac Marker Revenue Market Share by Company in 2021

Figure 30. Global Cardiac Marker Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Cardiac Marker Revenue Market Share by Geographic Region in 2021

Figure 32. Global Cardiac Marker Sales Market Share by Region (2017-2022)

Figure 33. Global Cardiac Marker Revenue Market Share by Country/Region in 2021

Figure 34. Americas Cardiac Marker Sales 2017-2022 (K Doses)

Figure 35. Americas Cardiac Marker Revenue 2017-2022 ($ Millions)

Figure 36. APAC Cardiac Marker Sales 2017-2022 (K Doses)

Figure 37. APAC Cardiac Marker Revenue 2017-2022 ($ Millions)

Figure 38. Europe Cardiac Marker Sales 2017-2022 (K Doses)

Figure 39. Europe Cardiac Marker Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Cardiac Marker Sales 2017-2022 (K Doses)

Figure 41. Middle East & Africa Cardiac Marker Revenue 2017-2022 ($ Millions)

Figure 42. Americas Cardiac Marker Sales Market Share by Country in 2021

Figure 43. Americas Cardiac Marker Revenue Market Share by Country in 2021

Figure 44. United States Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Cardiac Marker Sales Market Share by Region in 2021

Figure 49. APAC Cardiac Marker Revenue Market Share by Regions in 2021

Figure 50. China Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Cardiac Marker Sales Market Share by Country in 2021

Figure 57. Europe Cardiac Marker Revenue Market Share by Country in 2021

Figure 58. Germany Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Cardiac Marker Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Cardiac Marker Revenue Market Share by Country in 2021

Figure 65. Egypt Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Cardiac Marker Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Cardiac Marker in 2021

Figure 71. Manufacturing Process Analysis of Cardiac Marker

Figure 72. Industry Chain Structure of Cardiac Marker

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390